跳至主要内容
临床试验/NCT03469440
NCT03469440招募中不适用

Goal Directed Therapy Aiming to Optimise Oxygen Central Venous Saturation in Children Undergoing Cardiac Surgery: a Randomized and Prospective Clinical Trial

Instituto do Coracao2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2018年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
65
试验地点
2
主要终点
Lactate clearance

研究概览

简要总结

The purpose of this study is evaluate goal-directed therapy with continuous central venous saturation compared to standard therapy in children undergoing cardiac surgery.

详细描述

Pediatric patients undergoing cardiac surgery are at risk for adverse clinical outcomes due a inadequate tissue perfusion. Recent studies have been demonstraded which the monitorization of continuos central venous saturation could be benneficial. There is evidence that monitoring continues venous oxygen saturation (ScvO2) can be beneficial in patient outcomes, guided by ScvO2 therapy has been associated with improved outcomes in resuscitation of critically ill patients with sepsis and after congenital heart surgery complexa. The early detection and treatment of tissue hypoxia can prevent morbidity and mortality. tissue hypoxia may be a result of the imbalance between supply (DO2) and oxygen consumption (VO2). If the fault supply, oxygen consumption is maintained by increased oxygen extraction resulting in decreased central venous oxygen saturation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
— 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Elective cardiac surgery with cardiopulmonary bypass
  • Written informed consent

排除标准

  • Cardiac arrhythmia
  • Emergency operation
  • Hemodynamic instabillty (norepinephrine higher than 1 mcg/kg/min)
  • Neoplasia
  • Heart transplant
  • Participation in another study

结局指标

主要结局

Lactate clearance

时间窗: at the beginning of surgery up to 24 hours after surgery

(\[lactate initial - lactate delayed\]/lactate initial) ×100%

次要结局

  • Cardiac complications(within 30 days after cardiac surgery)
  • Renal complications(within 30 days after cardiac surgery)
  • Infection(within 30 days after cardiac surgery)
  • Length of ICU stay(within 30 days after cardiac surgery)
  • Length of Mechanical ventilation(within 30 days after cardiac surgery)
  • Vasopressors and inotropic therapy(within 30 days after cardiac surgery)
  • Length of hospital stay(within 30 days after cardiac surgery)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Filomena R B G Galas

Associate Professor of Anesthesiology Departament

Instituto do Coracao

研究点 (2)

Loading locations...

相似试验